Skip to main content

Karl Kieburtz, MD, MPH

Professor of Neurology and Center for Health + Technology • University of Rochester Medical Center

Professor of Neurology and Center for Health + Technology
University of Rochester Medical Center
Rochester, New York

Karl Kieburtz, MD, MPH, is a Professor of Neurology at the University of Rochester. Dr. Kieburtz was the founding Director of the Center for Human Experimental Therapeutics, which conducts learning phase clinical trials in a wide spectrum of disorders. He was also the initial Robert J. Joynt Professor in Neurology, and served as the Senior Associate Dean for Clinical Research and Director of the Clinical & Translational Science Institute, where he continues to have a senior advisory role.

Dr. Kieburtz’s primary clinical and research interests are neurodegenerative diseases affecting the basal ganglia. He was the principal investigator (PI) for the NINDS sponsored trials of neuroprotective agents for PD (NET-PD), served as the Chair of the Parkinson Study Group, and directs the Clinical Core for the Fox Foundation sponsored Parkinson Progression Marker Initiative. He has served as the PI for many multicenter clinical trials in Huntington disease (HD), including the first NIH-funded multicenter trial in HD (CARE HD), and the initial dosage ranging trials of Pridopidine. He previously served on and chaired the FDA Advisory Committee on Peripheral and Central Nervous System Disorders.

In 2009, he was one of the co-founders of Clintrex LLC, and continues to serve as President of the organization.

We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.